An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).

Conditions: Esophageal Cancer Interventions: Combination Product: Experimental: Arm 1 Organ preservation; Combination Product: Active Comparator: Arm 2 Surgery Sponsors: Ruijin Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials